Nanotop (Human Serum Albumin)

Human Serum Albumin, the active ingredient in Nanotop, is a plasma volume expander presented as a sterile intravenous solution for infusion use. It is employed to restore intravascular volume in patients with hypovolemia, hypoalbuminemia, extensive burns, or those requiring surgical fluid replacement, and is commonly administered in acute care settings to maintain hemodynamic stability under medical supervision.

GNH USA supplies Nanotop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies and clinics globally worldwide today.

Nanotop, a plasma volume expander, is used in clinical situations that require rapid restoration of circulating blood volume. - Hypovolemia: restores intravascular volume to improve blood pressure and tissue perfusion. - Hypoalbuminemia: increases plasma oncotic pressure, helping to correct low serum albumin levels. - Burns: provides essential colloid support to compensate for fluid losses in severe burn patients. - Surgical volume replacement: maintains hemodynamic stability during and after operative procedures.

Adverse reactions to Nanotop may vary in frequency and severity.

Common Side Effects: - Fever: mild elevation of body temperature following infusion. - Headache: transient headache occurring during or shortly after administration. - Nausea: occasional feeling of nausea without vomiting. - Hypotension: mild drop in blood pressure that resolves with monitoring.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical intervention. - Volume overload: excessive intravascular expansion leading to pulmonary edema.

Before using Nanotop, consider the following precautions to ensure safe administration. - Patient assessment: evaluate volume status and serum albumin levels prior to infusion. - Infusion rate: administer slowly and monitor vital signs to avoid rapid shifts. - Allergic history: screen for prior reactions to human albumin products. - Concomitant fluids: adjust other intravenous fluids to prevent fluid overload. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Nanotop can interact with certain medications and clinical conditions.

Major Interactions (Avoid): - Diuretics: may exacerbate hypovolemia if albumin is removed too quickly. - ACE inhibitors: increased risk of hypotension when combined with rapid volume expansion.

Moderate Interactions (Monitor Closely): - Anticoagulants: altered plasma volume may affect coagulation parameters; monitor INR or aPTT. - Vasopressors: concurrent use may require dose adjustments due to changes in intravascular volume. - Hypertonic solutions: simultaneous infusion can cause osmotic shifts; monitor electrolytes.